MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutationPhase 2 results ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation ...
The Myanmar military junta is using its new “Election Protection Law” to silence and intimidate critics ahead of its sham ...
SYDNEY, Dec. 10, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA) today announced new data from two presentations at the 2025 San Antonio Breast Cancer ...
During the 2016 election campaign, Donald Trump infamously asserted, “I could stand in the middle of Fifth Avenue and shoot ...
Welcome to the Fox News Politics newsletter, with the latest updates on the Trump administration, Capitol Hill and more Fox ...
New THINK! campaign warns younger motorists of life-changing consequences as police increase checks after a rise in ...
“In our real-world experience, [Yescarta] in relapsed or refractory follicular lymphoma showed durable responses and a ...
Proceeds to further advance clinical development of BH-30643, a first-in-class, macrocyclic, CNS-active, mutant-selective OMNI-EGFRTM inhibitor ...
Proceeds to further advance clinical development of BH-30643, a first-in-class, macrocyclic, CNS-active, mutant-selective OMNI-EGFRTM inhibitor for EGFR-mutant NSCLC, and BH-30236, a novel macrocyclic ...
Did you know that foods like walnuts and yogurt support better sleep? That acetaminophen is usually the better choice for fevers? That the simplest way to lead a happier life is to just ask yourself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback